VasoDrive-AP® (Casein Hydrolysate)
Renin-Angiotensin System (RAS) Modulation
The primary mechanism of action for the lactotripeptides in VasoDrive-AP®, Valyl-Prolyl-Proline (VPP) and Isoleucyl-Prolyl-Proline (IPP), is the inhibition of Angiotensin-Converting Enzyme (ACE; EC 3.4.15.1). ACE is a key zinc-dependent metalloprotease in the Renin-Angiotensin System (RAS), a critical regulator of blood pressure and fluid balance. ACE catalyzes the conversion of the decapeptide angiotensin I into the octapeptide angiotensin II, which is a powerful vasoconstrictor. Angiotensin II exerts its effects by binding to AT1 receptors on vascular smooth muscle cells, leading to contraction and an increase in blood pressure. Additionally, ACE is responsible for the degradation of bradykinin, a potent vasodilator.
VPP and IPP act as competitive inhibitors of ACE. Their proline-rich structure mimics the substrate-binding site of angiotensin I, allowing them to bind to the active site of the ACE enzyme. This competitive binding prevents ACE from converting angiotensin I to angiotensin II. The resulting decrease in circulating angiotensin II levels leads to reduced vasoconstriction and, consequently, vasodilation of blood vessels. This vasorelaxant effect lowers peripheral resistance and can lead to a reduction in both systolic and diastolic blood pressure. By inhibiting the degradation of bradykinin, these peptides may also potentiate its vasodilatory effects through nitric oxide (NO) pathways, further contributing to improved blood flow.
Pharmacokinetics
The provided sources do not contain specific pharmacokinetic data such as Tmax, bioavailability, or half-life for VasoDrive-AP® or its constituent peptides. Research on lactotripeptides suggests they can be absorbed intact from the gastrointestinal tract, though bioavailability can be variable. Once absorbed, they circulate and exert their inhibitory effects on ACE, primarily in the endothelium of blood vessels throughout the body.
What is VasoDrive-AP®? +
How does VasoDrive-AP® work? +
What is the best dose for VasoDrive-AP®? +
When is the best time to take VasoDrive-AP®? +
Does VasoDrive-AP® have any side effects? +
Do I need to cycle VasoDrive-AP®? +
Is VasoDrive-AP® better than generic casein hydrolysate? +
Who should take VasoDrive-AP®? +
Who should not take VasoDrive-AP®? +
Can I stack VasoDrive-AP® with other supplements? +
Is VasoDrive-AP® safe for long-term use? +
Can I get VasoDrive-AP® from food? +
Is there a loading phase for VasoDrive-AP®? +
Does VasoDrive-AP® interact with medications? +
Is VasoDrive-AP® a stimulant? +
What does the 'AP' in VasoDrive-AP® stand for? +
Will VasoDrive-AP® help me build muscle? +
Everything About VasoDrive-AP® (Casein Hydrolysate) Article
NOTE FOR EDITORS: The hub page content makes several claims about acute intra-workout pump sensations ('by your main working sets, the pump is undeniable') that are not supported by clinical literature. The clinical evidence supports blood pressure reduction over weeks, not acute workout pumps. This section should be revised to accurately represent the evidence base and qualify pump claims as mechanistically plausible but not directly studied. The claim that this ingredient has a 'well-documented mechanism' relative to other pump ingredients is also overstated given the absence of sports performance trials.
* These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare provider before beginning any supplement regimen.